Research progress of neurobrucellosis

doi:10.3760/cma.j.issn.1007-1245.2023.02.005

Abstract

Abstract:

Brucellosis is a common zoonotic disease caused by Brucella infection; the main source of infection is sheep and cattle. Brucella can be transmitted to humans through a variety of ways. Brucella infection in humans often leads to complications in several organs and systems. Neurobrucellosis has a low incidence but is serious, with a risk of misdiagnosis and mismanagement, which can lead to disability and death. In this paper, a retrospective analysis of relevant literature reports was conducted to improve clinicians' understanding of neurobrucellosis and to achieve early diagnosis and treatment.

Key words:

Neurobrucellosis, Brucella, Meningitis

摘要：

布鲁菌病是由布鲁菌感染引起的常见人畜共患病，主要传染源是羊和牛，布鲁菌可通过多种途径传染给人类。人感染布鲁菌常导致多个器官系统出现并发症，神经型布鲁菌病发生率低，病情严重，易发生误诊误治，可致残和死亡。本文对相关文献报道进行了回顾性分析，以期提高临床医师对神经型布鲁菌病的认识，做到早诊断早治疗。

关键词:

神经型布鲁菌病, 布鲁菌, 脑膜炎

Lin Yiru, Wang Bo, Ding Guofeng.

Research progress of neurobrucellosis [J]. International Medicine and Health Guidance News, 2023, 29(2): 166-.

林怡如王波丁国锋.

神经型布鲁菌病的研究进展 [J]. 国际医药卫生导报, 2023, 29(2): 166-.

References

[1] Dean AS, Crump L, Greter H, et al. Clinical manifestations of human brucellosis: a systematic review and meta-analysis [J]. PLoS Negl Trop Dis, 2012, 6(12):e1929. DOI: 10.1371/journal.pntd.0001929.
[2] Vila A, Pagella H, Vera Bello G, Vicente A. Brucella suis bacteremia misidentified as Ochrobactrum anthropi by the VITEK 2 system. J Infect Dev Ctries. 2016 Apr 28;10(4):432-6. doi: 10.3855/jidc.7532. PMID: 27131010.
[3] 刘志国,王妙,崔步云,等. 布鲁氏菌病并发症及治疗研究进展[J]. 中国人兽共患病学报,2019,35(5):447-454. DOI:10.3969/j.issn.1002-2694.2019.00.045.
[4] Samdani PG, Patil S. Neurobrucellosis[J]. Indian Pediatr, 2003, 40(6): 565-568.
[5] Gul HC, Erdem H, Bek S. Overview of neurobrucellosis: a pooled analysis of 187 cases [J]. Int J Infect Dis, 2009, 13(6):e339-e343. DOI: 10.1016/j.ijid.2009.02.015.
[6] 王栋才,赵新芳,白贺霞. 人布氏杆菌病的治疗研究进展[J]. 中国中医药现代远程教育,2018,16(11):147-149. DOI:10.3969/j.issn.1672-2779.2018.11.068.
[7] 王赢.2020年全国布鲁菌病监测结果分析[J].中国地方病防治,2021,36(6):565-569.
[8] Dreshaj S, Shala N, Dreshaj G, et al. Clinical manifestations in 82 neurobrucellosis patients from kosovo [J]. Mater Sociomed, 2016, 28(6): 408-411. DOI: 10.5455/msm. 2016.28.408-411.
[9] Zhao S, Cheng Y, Liao Y, et al. Treatment efficacy and risk factors of neurobrucellosis [J]. Med Sci Monit, 2016, 22: 1005-1012. DOI: 10.12659/msm.897947.
[10] Rossi M, Tascini C, Carannante N, et al. Neurobrucellosis: diagnostic and clinical management of an atypical case [J]. New Microbiol, 2018, 41(2): 165-167.
[11] Solera J, Solís García Del Pozo J. Treatment of pulmonary brucellosis: a systematic review [J]. Expert Rev Anti Infect Ther, 2017, 15(1):33-42. DOI: 10.1080/14787210.2017. 1254042.
[12] Galińska EM, Zagórski J. Brucellosis in humans--etiology, diagnostics, clinical forms [J]. Ann Agric Environ Med, 2013, 20(2): 233-238.
[13] 李兰娟, 任红. 传染病学[M]. 9版. 北京: 人民卫生出版社, 2018:92-101.
[14] Tuon FF, Gondolfo RB, Cerchiari N. Human-to-human transmission of Brucella - a systematic review [J]. Trop Med Int Health, 2017, 22(5): 539-546. DOI: 10.1111/tmi.12856.
[15] Yumuk Z, O'Callaghan D. Brucellosis in Turkey -- an overview [J]. Int J Infect Dis, 2012, 16(4): e228-e235. DOI: 10.1016/j.ijid.2011.12.011.
[161] 成岩,白靓,张树军.我国布鲁氏菌感染的研究现状及展望[J].内蒙古民族大学学报(自然科学版),2012,27(3):343-346. DOI:10.14045/j.cnki.15-1220.2012.03.034.
[17] Kizilkilic O, Calli C. Neurobrucellosis [J]. Neuroimaging Clin N Am, 2011, 21(4): 927-937, ix. DOI: 10.1016/j.nic.2011.07.008. PMID: 22032507.
[18] Miraglia MC, Rodriguez AM, Barrionuevo P, et al. Brucella abortus traverses brain microvascular endothelial cells using infected monocytes as a trojan horse [J]. Front Cell Infect Microbiol, 2018, 8: 200. DOI: 10.3389/fcimb.2018.00200.
[19] Miraglia MC, Costa Franco MM, Rodriguez AM, et al. Glial cell-elicited activation of brain microvasculature in response to brucella abortus infection requires ASC inflammasome-dependent il-1β production [J]. J Immunol, 2016, 196(9): 3794-3805. DOI: 10.4049/jimmunol.1500908.
[20] Haji-Abdolbagi M, Rasooli-Nejad M, Jafari S, et al. Clinical and laboratory findings in neurobrucellosis: review of 31 cases [J]. Arch Iran Med, 2008, 11(1): 21-25.
[21] Aziz-Ahari A, Mamishi S, Dadkhah A, et al. Neurobrucellosis in a 9-year-old girl [J]. J Radiol Case Rep, 2019, 13(12): 13-19. DOI: 10.3941/jrcr.v13i12.3734.
[22] Akdeniz H, Irmak H, Anlar O, et al. Central nervous system brucellosis: presentation, diagnosis and treatment [J]. J Infect, 1998, 36(3): 297-301. DOI: 10.1016/s0163- 4453(98) 94279-7.
[23] 米继伟,张希璐,付晶,等.神经型布鲁氏杆菌病[J].世界最新医学信息文摘,2018,18(74):295.
[24] Bingöl A, Togay-Işikay C. Neurobrucellosis as an exceptional cause of transient ischemic attacks [J]. Eur J Neurol, 2006, 13(5): 544-548. DOI: 10.1111/j.1468-1331. 2006.01286.x.
[25] Yetkin MA, Bulut C, Erdinc FS, et al. Evaluation of the clinical presentations in neurobrucellosis [J]. Int J Infect Dis, 2006, 10(6): 446-452. DOI: 10.1016/j.ijid.2006. 05.007.
[26] 任彩云,张哲林,殷旭华,等. 神经型布氏杆菌病周围神经损害的临床与电生理研究[J]. 中国神经精神疾病杂志,2017,43(5):279-283. DOI:10.3969/j.issn.1002-0152. 2017.05.005.
[27] 丛琳,曲红岩. 神经型布氏杆菌病的临床特点(附5例报告)[J]. 中国神经精神疾病杂志,2012,38(4):225-228. DOI:10.3969/j.issn.1002-0152.2012.04.007.
[28] Adaletli I, Albayram S, Gurses B, et al. Vasculopathic changes in the cerebral arterial system with neurobrucellosis [J]. AJNR Am J Neuroradiol, 2006, 27(2): 384-386.
[29] Ceran N, Turkoglu R, Erdem I, et al. Neurobrucellosis: clinical, diagnostic, therapeutic features and outcome. Unusual clinical presentations in an endemic region [J]. Braz J Infect Dis, 2011, 15(1): 52-59.
[30] Erdem H, Senbayrak S, Meriç K, et al. Cranial imaging findings in neurobrucellosis: results of Istanbul-3 study [J]. Infection, 2016, 44(5): 623-631. DOI: 10.1007/s15010-016-0901-3.
[31] Al-Sous MW, Bohlega S, Al-Kawi MZ, et al. Neurobrucellosis: clinical and neuroimaging correlation [J]. AJNR Am J Neuroradiol, 2004, 25(3):395-401.
[32] 刘佳音,姜海. 我国布鲁氏菌病诊断方法应用及思考[J]. 中华流行病学杂志,2021,42(1):160-163. DOI:10.3760/cma.j.cn112338-20200516-00734.
[33] Kattar MM, Zalloua PA, Araj GF, et al. Development and evaluation of real-time polymerase chain reaction assays on whole blood and paraffin-embedded tissues for rapid diagnosis of human brucellosis [J]. Diagn Microbiol Infect Dis, 2007, 59(1):23-32. DOI: 10.1016/j.diagmicrobio. 2007.04.002.
[34] 马汇丰,张哲林. 炎性因子白细胞介素1β和白细胞介素6在神经型布鲁菌病诊断中的应用价值[J]. 中华传染病杂志,2020,38(2):113-116. DOI: 10.3760/cma.j.issn. 1000-6680. 2020.02.012.
[35] Erdem H, Ulu-Kilic A, Kilic S, et al. Efficacy and tolerability of antibiotic combinations in neurobrucellosis: results of the Istanbul study [J]. Antimicrob Agents Chemother, 2012, 56(3): 1523-1528. DOI: 10.1128/AAC.05974-11.
[36] Ersoy Y, Sonmez E, Tevfik MR, et al. Comparison of three different combination therapies in the treatment of human brucellosis [J]. Trop Doct, 2005, 35(4): 210-212. DOI: 10.1258/004947505774938765.
[37] N T, B N, O O, et al. Anti-Brucella activity of Caryopteris mongolica Bunge root extract against Brucella melitensis infection in mice [J]. BMC Complement Altern Med, 2018, 18(1): 144. DOI: 10.1186/s12906-018-2220-y.
[38] 王新梅,钟敏,蒋玉凤,等. 布鲁菌病继发噬血细胞综合征1例并文献复习[J]. 中国感染与化疗杂志,2022,22(1):51-55. DOI:10.16718/j.1009-7708.2022.01.010.
[39] Gul HC, Erdem H, Gorenek L, et al. Management of neurobrucellosis: an assessment of 11 cases [J]. Intern Med, 2008, 47(11): 995-1001. DOI: 10.2169/internalmedicine. 47.0866.
[40] 杨勇,段博芳,董国栋,等. 人畜间布鲁氏菌病研究进展[J]. 中国动物检疫,2020,37(4):76-83. DOI: 10.3969/j.issn. 1005-944X.2020.04.016.
[41] Perkins SD, Smither SJ, Atkins HS. Towards a Brucella vaccine for humans [J]. FEMS Microbiol Rev, 2010, 34(3): 379-394. DOI: 10.1111/j.1574-6976.2010.00211.x.
[42] 景志刚,严家瑞,范伟兴. 布鲁氏菌病疫苗研究进展[J]. 中国人兽共患病学报,2016,32(2):188-199. DOI:10.3969/j.issn.1002-2694.2016.02.018.
[43] Khan MZ, Zahoor M. An overview of brucellosis in cattle and humans, and its serological and molecular diagnosis in control strategies [J]. Trop Med Infect Dis, 2018, 3(2):65. DOI: 10.3390/tropicalmed3020065.